Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Basal Cell × Opdualag × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 6 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Recurrence 1 Patient Preference 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1 Brain Neoplasms 1

Interventions

HhAntag691 13 Aminolevulinic Acid 5 sonidegib 4 Nivolumab 3 tazarotene 2 daromun 2 cemiplimab 2 Specimen Handling 2 Radiotherapy 2 IPI-926 2 Drug Evaluation 2 Celecoxib 2 3-ingenyl angelate 2 talimogene laherparepvec 1 remetinostat 1 relatlimab 1 endonuclease V, phage T4 1 Triamcinolone 1 Sutures 1 Surgical Procedures, Operative 1 Solutions 1 Papillomavirus Vaccines 1 Opdualag 1 Niacinamide 1 NVP-BKM120 1 Methotrexate 1 Magnetic Resonance Spectroscopy 1 Lighting 1 Ipilimumab 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06624475 2026-02-05

NEON

University of California, San Diego

Phase 2 Recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡